Colorectal Cancer Trial, Recruiting NCT06485609 Sponsor: Sun Yat-sen University Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT06485609
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 75 years old
  • People who have been diagnosed with a type of colon cancer called adenocarcinoma, confirmed by laboratory testing of tissue
  • People whose tumor is located in a specific part of the large bowel — from the cecum (the start of the large intestine) to the right third of the transverse colon (the upper middle section)
  • People whose CT scan shows right colon cancer at a certain stage — meaning the cancer has spread to nearby lymph nodes but not to distant parts of the body (T1–T4a N+ M0)
  • People who have been assessed as generally fit enough for surgery, based on standard health scoring tools (ASA scores I–III and ECOG score of 0 or 1) (confirm with trial site)
  • People, or their family members, who are able to understand the study and are willing to take part by signing a consent form

Who may not be able to join:

  • People who have more than one primary colon cancer occurring at the same time or at different times
  • People who need emergency surgery due to a blocked, perforated, or bleeding bowel
  • People who are not suitable candidates for laparoscopic (keyhole) surgery — for example, due to significant scarring from previous major abdominal surgery, or other reasons that make the procedure unsafe (confirm with trial site)
  • People who are pregnant or breastfeeding
  • People who have a history of serious mental illness
  • People who have a known allergy to iodine
  • People who have had another type of cancer within the last five years
  • People who have previously received chemotherapy or radiation therapy before surgery for this cancer
  • People who have had unstable chest pain (angina) or a heart attack within the last 6 months
  • People who have been taking oral or injected corticosteroid medication continuously within the last month

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 38455369

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
10 August 2024
Est. completion
1 June 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Disease-free survival rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov